Fintel reports that on October 26, 2026, Deutsche Bank initiated coverage of Agilent Technologies (NYSE:A) (LSE:0HAV) with a Buy recommendation.Agilent Technologies, Inc., based in the United States, is a prominent player in the analytical laboratory instrument manufacturing indu

Deutsche Bank Initiates Coverage of Agilent Technologies at Buy

Abbott's Q3 earnings miss weighs on its stock despite double-digit revenue growth and expanding margins, while lower 2026 sales guidance raises concerns.

ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up

Looking at the universe of stocks we cover at Dividend Channel, on 10/6/26, Agilent Technologies, Inc. (Symbol: A) will trade ex-dividend, for its quarterly dividend of $0.255, payable on 10/28/26.  As a percentage of A's recent stock price of $169.39, this dividend works out to

Agilent Technologies About To Put More Money In Your Pocket (A)

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.

3 Healthcare Stocks That Fall Short

Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies, Inc. News